Search results
Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now
Motley Fool via Yahoo Finance· 21 hours agoTwo of these ultra-high-yield S&P 500 dividend stocks are nothing short of screaming buys right now....
How the love story between von der Leyen and Pfizer turned sour
Euronews via Yahoo News· 5 days agoFrom making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and...
3 Blue-Chip Stocks to Buy on the Dip: May 2024
InvestorPlace· 17 hours agoWhile the latest Commerce Department report showed a notable deceleration in GDP growth, experts attribute much of this to robust spending on imported...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoOctapharma USA, Inc. has appointed pharmaceutical industry veteran Kelly Hearn as Vice President of Commercial Development & Marketing, assuming immediate leadership of the product marketing ...
2 Top Growth Stocks Down 24% and 50% to Buy With $100
Motley Fool via Yahoo Finance· 6 days agoIf you have even $100 to invest in stocks right now, here are two top healthcare companies that the...
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 5 days agoInvestors were betting on the companies' coronavirus vaccine candidates and their ability to bring in billions of dollars in revenue. Moderna fared well,...
'New era of growth': AstraZeneca sets out bold plans for $80bn revenues by 2030
Evening Standard via Yahoo Finance· 20 hours agoThe new drugs include a “first in class” Asthma treatment using cloned antibodies currently in...
AltruBio lands up to $225M after shift to immune drug research
BioPharma Dive via Yahoo Finance· 20 hours agoAltruBio is among the beneficiaries of the investment surge. Since rebranding and bringing in former...
BIO to restructure, lay off staff in shakeup of lobbying group
BioPharma Dive via Yahoo Finance· 2 days agoIn recent months, Pfizer, Takeda Pharmaceuticals and UCB all left BIO, while others, including...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 7 days agoAfter hitting a two-year high in February, biotech stocks sloughed off in April but have started to...